| pubmed-article:9696950 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9696950 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9696950 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
| pubmed-article:9696950 | lifeskim:mentions | umls-concept:C0054836 | lld:lifeskim |
| pubmed-article:9696950 | lifeskim:mentions | umls-concept:C0205169 | lld:lifeskim |
| pubmed-article:9696950 | lifeskim:mentions | umls-concept:C1522166 | lld:lifeskim |
| pubmed-article:9696950 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9696950 | pubmed:dateCreated | 1998-10-19 | lld:pubmed |
| pubmed-article:9696950 | pubmed:abstractText | Carvedilol, a beta-adrenoceptor blocking agent with additional alpha(1)-adrenoceptor blocking properties, has been shown to improve left ventricular function in chronic heart failure (CHF). However, its effect on mortality has recently been the subject of controversial discussion. The aim of this meta-analysis is to review the data on mortality from two large study programs (the US Carvedilol Heart Failure Study and the study by the Australia/New Zealand Heart Failure Research Collaborative Group) on additional carvedilol treatment in CHF standard therapy and to analyse the design and limitations of the individual studies. | lld:pubmed |
| pubmed-article:9696950 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9696950 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9696950 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9696950 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9696950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9696950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9696950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9696950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9696950 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9696950 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:9696950 | pubmed:issn | 0031-6970 | lld:pubmed |
| pubmed-article:9696950 | pubmed:author | pubmed-author:WehlingMM | lld:pubmed |
| pubmed-article:9696950 | pubmed:author | pubmed-author:SchmidtB MBM | lld:pubmed |
| pubmed-article:9696950 | pubmed:author | pubmed-author:JansonC PCP | lld:pubmed |
| pubmed-article:9696950 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9696950 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:9696950 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9696950 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9696950 | pubmed:pagination | 281-5 | lld:pubmed |
| pubmed-article:9696950 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:9696950 | pubmed:meshHeading | pubmed-meshheading:9696950-... | lld:pubmed |
| pubmed-article:9696950 | pubmed:meshHeading | pubmed-meshheading:9696950-... | lld:pubmed |
| pubmed-article:9696950 | pubmed:meshHeading | pubmed-meshheading:9696950-... | lld:pubmed |
| pubmed-article:9696950 | pubmed:meshHeading | pubmed-meshheading:9696950-... | lld:pubmed |
| pubmed-article:9696950 | pubmed:meshHeading | pubmed-meshheading:9696950-... | lld:pubmed |
| pubmed-article:9696950 | pubmed:meshHeading | pubmed-meshheading:9696950-... | lld:pubmed |
| pubmed-article:9696950 | pubmed:meshHeading | pubmed-meshheading:9696950-... | lld:pubmed |
| pubmed-article:9696950 | pubmed:meshHeading | pubmed-meshheading:9696950-... | lld:pubmed |
| pubmed-article:9696950 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9696950 | pubmed:articleTitle | Assuming the worst may not be bad at all. Carvedilol in heart failure treatment. | lld:pubmed |
| pubmed-article:9696950 | pubmed:affiliation | Institute for Clinical Pharmacology, Faculty of Clinical Medicine at Mannheim, Ruprecht Karls University Heidelberg. | lld:pubmed |
| pubmed-article:9696950 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9696950 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:9696950 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9696950 | lld:pubmed |
